Deutsche Bank
XGN icon

Deutsche Bank’s Exagen XGN Stock Holding History

Deutsche Bank’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,660
Closed -$137K – 4054
2022
Q3 		$137K Sell
50,660
-22,684
-31% -$127K ﹤0.01% 3166
2022
Q2 		$421K Sell
73,344
-5,609
-7% -$32.7K ﹤0.01% 2716
2022
Q1 		$634K Sell
78,953
-658
-0.8% -$5.67K ﹤0.01% 2614
2021
Q4 		$926K Sell
79,611
-139,588
-64% -$1.63M ﹤0.01% 2480
2021
Q3 		$2.98M Sell
219,199
-86,564
-28% -$1.15M ﹤0.01% 1817
2021
Q2 		$4.58M Buy
305,763
+302,685
+9,834% +$4.64M ﹤0.01% 1595
2021
Q1 		$54K Sell
3,078
-288
-9% -$5.13K ﹤0.01% 4219
2020
Q4 		$44K Buy
3,366
+944
+39% +$13.3K ﹤0.01% 4138
2020
Q3 		$26K Buy
2,422
+224
+10% +$2.88K ﹤0.01% 4079
2020
Q2 		$27K Buy
2,198
+1,155
+111% +$15.6K ﹤0.01% 4006
2020
Q1 		$17K Sell
1,043
-66
-6% -$1.31K ﹤0.01% 3951
2019
Q4 		$28K Buy
+1,109
New +$19.7K ﹤0.01% 4196

Other funds holding XGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Deutsche Bank's XGN Position: Q4 2022 in Review

Deutsche Bank sold out of Exagen (XGN) in Q4 2022, closing a stake of 50,660 shares — an estimated $137K sold.

Deutsche Bank first reported a position in XGN in Q4 2019 and held it in 12 quarters. The position peaked at $4.58M in Q2 2021. 31 funds tracked by Wall St. Rank hold XGN as of Q4 2022.

  • Deutsche Bank reported no remaining Exagen position as of Q4 2022 after selling out during the quarter.
  • Deutsche Bank sold 50,660 Exagen shares in Q4 2022, an estimated $137K.
  • Deutsche Bank first reported a position in Exagen in Q4 2019 and held it in 12 quarters.
  • Deutsche Bank's Exagen position peaked at $4.58M in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Exagen as of Q4 2022.

Based on Deutsche Bank's 13F filing for Q4 2022, filed 13 Feb 2023.